Dr. Krishna Prasad – Medgate Today

Granules India enters the high growing peptide segment and CDMO business by acquiring Senn Chemicals AG

February 26, 2025

8:03 am

Granules India Limited (BSE: 532482, NSE: GRANULES) today announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. Senn develops and manufactures, Peptides and Peptides based applications for its global customers, providing contract research, development, and manufacturing services.

POST TAGS:

Granules India’s Unit V Facility Secures US FDA EIR with ‘No Action Indicated’ Status

November 9, 2024

8:16 am

News Update

admin

Granules India Limited, a leading pharmaceutical manufacturing company, is pleased to announce that it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its Unit V facility located at Jawaharlal Nehru Pharma City (JNPC), Anakapalli District, Parawada Mandal,

POST TAGS:

Dr. Krishna Prasad Food Global Health Granules India Health Oncology Pharma pharmaceutical Therapeutic

Granules India enters the high growing peptide segment and CDMO business by acquiring Senn Chemicals AG

POST TAGS:

Granules India’s Unit V Facility Secures US FDA EIR with ‘No Action Indicated’ Status

POST TAGS:

FIND US

ADDRESS

FOLLOW US ON SOCIAL MEDIA